Early research (Phase 1)Active Not RecruitingNCT02521844
What this trial is testing
Evaluate the Safety and Tolerability of ETC-1922159 as a Single Agent and in Combination With Pembrolizumab in Advanced Solid Tumours
Who this might be right for
Solid Tumors
EDDC (Experimental Drug Development Centre), A*STAR Research Entities 89